Metformin plus EGFR TKIs for lung adenocarcinoma.
Journal: 2019/September - The Lancet Oncology
ISSN: 1474-5488
Relations:
Diseases
(1)
Drugs
(2)
Genes
(1)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.